Hunea, I.; Riscanu, L.; Girlescu, N.; Diac, M.; Knieling, A.; David, S.; Furnica, C.; Lucasevici, C.; Dragomir, I.C.; Iliescu, D.B.;
et al. Clinical-Pathological Study on Expressions β-APP, GFAP, NFL, Spectrin II, CD68 to Verify Diffuse Axonal Injury Diagnosis, Grade and Survival Interval. Appl. Sci. 2022, 12, 3638.
https://doi.org/10.3390/app12073638
AMA Style
Hunea I, Riscanu L, Girlescu N, Diac M, Knieling A, David S, Furnica C, Lucasevici C, Dragomir IC, Iliescu DB,
et al. Clinical-Pathological Study on Expressions β-APP, GFAP, NFL, Spectrin II, CD68 to Verify Diffuse Axonal Injury Diagnosis, Grade and Survival Interval. Applied Sciences. 2022; 12(7):3638.
https://doi.org/10.3390/app12073638
Chicago/Turabian Style
Hunea, Iuliana, Laura Riscanu, Nona Girlescu, Madalina Diac, Anton Knieling, Sofia David, Cristina Furnica, Codrin Lucasevici, Irina Catrinel Dragomir, Diana Bulgaru Iliescu,
and et al. 2022. "Clinical-Pathological Study on Expressions β-APP, GFAP, NFL, Spectrin II, CD68 to Verify Diffuse Axonal Injury Diagnosis, Grade and Survival Interval" Applied Sciences 12, no. 7: 3638.
https://doi.org/10.3390/app12073638
APA Style
Hunea, I., Riscanu, L., Girlescu, N., Diac, M., Knieling, A., David, S., Furnica, C., Lucasevici, C., Dragomir, I. C., Iliescu, D. B., & Ciocoiu, M.
(2022). Clinical-Pathological Study on Expressions β-APP, GFAP, NFL, Spectrin II, CD68 to Verify Diffuse Axonal Injury Diagnosis, Grade and Survival Interval. Applied Sciences, 12(7), 3638.
https://doi.org/10.3390/app12073638
